G1 Therapeutics joins a growing biotech winners circle with $105M IPO
G1 Therapeutics is now the latest in a string of biotech IPOs to start out with a hit on its price range. The Research …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
